TPST Q1 2026 Earnings Deep EPS Miss Highlights ClinicalStage Biotech Challenges BK Q1 2026 Earnings EPS Surpasses Estimates by 1326 CLDI Q4 2025 Earnings Smallerthanexpected loss highlights progress in clinicalstage biotherapeutics HOVR Q1 2026 Earnings EPS Misses Estimates as PreRevenue Company Focuses on Development RSG Q1 2026 Earnings EPS Beat Driven by Operational Efficiency Kenon Holdings Q2 2025 Earnings Positive EPS of 010 Amid Limited Disclosures